Header cover image

U.S. Biotech Industry Analysis

UpdatedMar 18, 2024
DataAggregated Company Financials
Companies583
  • 7D-2.1%
  • 3M9.3%
  • 1Y10.4%
  • YTDn/a

In the last week, the Biotech industry is down 2.1% with Amgen down the most at 2.4%. In the past year, the industry has gained 10%. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the U.S. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 18 Mar 2024US$1.2tUS$167.4b-US$22,071,849,383.6413.9x-53.2x7x
Wed, 14 Feb 2024US$1.1tUS$168.9b-US$20,817,013,760.7018x-54.6x6.7x
Fri, 12 Jan 2024US$1.4tUS$204.8b-US$22,495,274,678.0019.2x-64.1x7x
Sun, 10 Dec 2023US$1.3tUS$204.6b-US$22,091,414,218.0018.7x-58.3x6.3x
Tue, 07 Nov 2023US$1.2tUS$203.9b-US$22,185,418,652.0018.9x-56x6.1x
Thu, 05 Oct 2023US$1.2tUS$207.3b-US$13,076,809,948.0016.7x-94.9x6x
Sat, 02 Sep 2023US$1.3tUS$207.6b-US$12,424,624,459.0018.4x-104.2x6.2x
Mon, 31 Jul 2023US$1.2tUS$186.0b-US$15,168,211,533.0014.7x-76.1x6.2x
Wed, 28 Jun 2023US$1.1tUS$186.3b-US$16,125,527,732.0013.5x-69.1x6x
Fri, 26 May 2023US$1.1tUS$185.9b-US$15,950,003,280.0011.5x-71.8x6.2x
Sun, 23 Apr 2023US$1.2tUS$198.4b-US$3,214,788,122.0013.9x-370.1x6x
Tue, 21 Mar 2023US$1.1tUS$199.3b-US$3,748,498,766.0012.7x-301.2x5.7x
Thu, 16 Feb 2023US$1.2tUS$202.5bUS$17.8m16.3x64811.8x5.7x
Sat, 14 Jan 2023US$1.2tUS$203.7bUS$1.8b14.5x670.8x5.8x
Mon, 12 Dec 2022US$1.1tUS$202.7bUS$1.4b14.6x811.7x5.6x
Wed, 09 Nov 2022US$1.1tUS$204.5bUS$3.9b14.4x280.2x5.3x
Fri, 07 Oct 2022US$1.1tUS$206.2bUS$5.5b15.1x193.6x5.1x
Sun, 04 Sep 2022US$1.0tUS$206.4bUS$6.2b14.6x167.9x5x
Tue, 02 Aug 2022US$1.0tUS$212.2bUS$11.4b15.4x90.7x4.9x
Thu, 30 Jun 2022US$1.0tUS$212.2bUS$11.0b15.7x94.5x4.9x
Sat, 28 May 2022US$1.0tUS$212.7bUS$11.1b16.1x92.8x4.8x
Mon, 25 Apr 2022US$1.2tUS$226.6bUS$14.7b17.8x81.5x5.3x
Wed, 23 Mar 2022US$1.3tUS$221.9bUS$10.6b19.8x122.3x5.9x
Fri, 18 Feb 2022US$1.2tUS$216.4bUS$5.7b21.9x214.8x5.7x
Sun, 16 Jan 2022US$1.3tUS$212.1bUS$2.5b24.4x527.3x6.2x
Tue, 14 Dec 2021US$1.4tUS$211.9bUS$3.1b25.2x449.8x6.7x
Thu, 11 Nov 2021US$1.5tUS$204.8b-US$58,717,099.0025.4x-24760.2x7.1x
Sat, 09 Oct 2021US$1.5tUS$196.3b-US$2,607,286,814.0023.3x-558.7x7.4x
Mon, 06 Sep 2021US$1.6tUS$196.4b-US$2,275,254,373.5622.4x-705.5x8.2x
Wed, 04 Aug 2021US$1.6tUS$197.0b-US$1,413,253,338.5822.6x-1110.5x8x
Sat, 08 May 2021US$1.4tUS$174.8b-US$11,096,405,382.5522.2x-127.4x8.1x
Price to Earnings Ratio

-125.6x


Total Market Cap: US$1.4tTotal Earnings: -US$10,804,700,199.55Total Revenue: US$174.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Biotech Industry Price to Earnings3Y Average -29.9x202220232024
Current Industry PE
  • Investors are optimistic on the American Biotechnology industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 6.3x is lower than the industry's current PS ratio of 7.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does U.S. Biotech compare with similar industries?

US Market-0.10%
Healthcare-0.95%
Biotech-2.11%
Biotech-2.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SGEN SeagenUS$228.744.5%
+US$1.8b
76.5%PS18.8x
GERN GeronUS$3.3657.0%
+US$666.2m
36.6%PS7741.6x
BGNE BeiGeneUS$170.003.3%
+US$584.1m
-23.8%PS7.2x
IMGN ImmunoGenUS$31.236.6%
+US$516.6m
617.9%PS29.1x
TALS Talaris TherapeuticsUS$27.20-4.9%
US$430.9m
91.5%PB3.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

KRTX

US$329.83

Karuna Therapeutics

7D

3.3%

1Y

80.7%

GERN

US$3.36

Geron

7D

57.0%

1Y

36.6%

BGNE

US$170.00

BeiGene

7D

3.3%

1Y

-23.8%

GILD

US$73.69

Gilead Sciences

7D

-2.2%

1Y

-7.3%

MRNA

US$103.85

Moderna

7D

-7.3%

1Y

-32.8%

BNTX

US$92.48

BioNTech

7D

-4.0%

1Y

-30.0%

ACAD

US$18.48

ACADIA Pharmaceuticals

7D

-23.4%

1Y

-6.5%

RNA

US$24.42

Avidity Biosciences

7D

16.2%

1Y

21.7%

IMGN

US$31.23

ImmunoGen

7D

6.6%

1Y

617.9%

CGON

US$38.52

CG Oncology

7D

10.1%

1Y

n/a

SGEN

US$228.74

Seagen

7D

4.5%

1Y

76.5%

TALS

US$27.20

Talaris Therapeutics

7D

-4.9%

1Y

91.5%